Skip to main content

Peer Review reports

From: Profile of judicialization in access to antineoplastic drugs and their costs: a cross-sectional, descriptive study based on a set of all lawsuits filed between 2016 and 2018 in a state in the Northeast Region of Brazil

Original Submission
30 Nov 2021 Submitted Original manuscript
22 Feb 2022 Reviewed Reviewer Report - John Alimamy Kabba
23 Feb 2022 Reviewed Reviewer Report
22 Mar 2022 Author responded Author comments - Fábio Henrique Cavalcanti Oliveira
Resubmission - Version 2
22 Mar 2022 Submitted Manuscript version 2
23 Mar 2022 Author responded Author comments - Fábio Henrique Cavalcanti Oliveira
Resubmission - Version 3
23 Mar 2022 Submitted Manuscript version 3
30 Mar 2022 Reviewed Reviewer Report - John Alimamy Kabba
19 Apr 2022 Reviewed Reviewer Report
10 Jun 2022 Author responded Author comments - Fábio Henrique Cavalcanti Oliveira
Resubmission - Version 4
10 Jun 2022 Submitted Manuscript version 4
22 Jun 2022 Author responded Author comments - Fábio Henrique Cavalcanti Oliveira
Resubmission - Version 5
22 Jun 2022 Submitted Manuscript version 5
3 Aug 2022 Author responded Author comments - Fábio Henrique Cavalcanti Oliveira
Resubmission - Version 6
3 Aug 2022 Submitted Manuscript version 6
Publishing
8 Aug 2022 Editorially accepted
26 Sep 2022 Article published 10.1186/s12889-022-14199-1

You can find further information about peer review here.

Back to article page